rs2018683
From SNPedia
| Orientation | plus |
| Stabilized | plus |
| Make rs2018683(G;G) |
| Make rs2018683(G;T) |
| Make rs2018683(T;T) |
| Reference | GRCh38 38.1/141 |
| Chromosome | 7 |
| Position | 28974579 |
| is a | snp |
| is | mentioned by |
| dbSNP | rs2018683 |
| dbSNP (classic) | rs2018683 |
| ClinGen | rs2018683 |
| ebi | rs2018683 |
| HLI | rs2018683 |
| Exac | rs2018683 |
| Gnomad | rs2018683 |
| Varsome | rs2018683 |
| LitVar | rs2018683 |
| Map | rs2018683 |
| PheGenI | rs2018683 |
| Biobank | rs2018683 |
| 1000 genomes | rs2018683 |
| hgdp | rs2018683 |
| ensembl | rs2018683 |
| geneview | rs2018683 |
| scholar | rs2018683 |
| rs2018683 | |
| pharmgkb | rs2018683 |
| gwascentral | rs2018683 |
| openSNP | rs2018683 |
| 23andMe | rs2018683 |
| SNPshot | rs2018683 |
| SNPdbe | rs2018683 |
| MSV3d | rs2018683 |
| GWAS Ctlg | rs2018683 |
| GMAF | 0.3976 |
| Max Magnitude | 0 |
| ? | (G;G) (G;T) (T;T) | 28 |
|---|---|---|
|
| ||
| GWAS snp | |
|---|---|
| PMID | [PMID 23478653] |
| Trait | Response to irinotecan and platinum-based chemotherapy in non-small-cell lung cancer |
| Title | A genome-wide association study of survival in small-cell lung cancer patients treated with irinotecan plus cisplatin chemotherapy. |
| Risk Allele | T |
| P-val | 8E-7 |
| Odds Ratio | 7.80 [3.4-17.7] |
